Commentary: Using <scp>QbTest</scp> for monitoring pharmacological treatment response in <scp>ADHD</scp> – are we there yet?

Individuals with attention-deficit/hyperactivity disorder (ADHD) exhibit varied responses to pharmacological treatments (e.g. stimulants and non-stimulants). Accurately and promptly detecting treatment-related improvements, response failure, or deterioration poses significant challenges, as current monitoring primarily relies on subjective ratings. In this commentary, we critically evaluate the evidence supporting the use of QbTest for objectively monitoring ADHD treatment response in clinical practice. We also offer recommendations for future research, advocating for rigorous clinical trials and longitudinal studies to further explore the potential utilisation of QbTest and other tools for monitoring treatment responses in individuals with ADHD.

Authors

Institutions

Publication Details

Journal
Journal of Child Psychology and Psychiatry
Published
2024-11-08
DOI
https://doi.org/10.1111/jcpp.14071
Primary Topic
Attention Deficit Hyperactivity Disorder
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Commentary: Using QbTest for monitoring pharmacological treatment response in ADHD – are we there yet?

Samuele Cortese, Chris Hollis, Anita Thapar, Emily Simonoff et al.
Journal of Child Psychology and Psychiatry
Attention Deficit Hyperactivity Disorder
article

Commentary: Using QbTest for monitoring pharmacological treatment response in ADHD – are we there yet?

Samuele Cortese, Chris Hollis, Anita Thapar, Emily Simonoff, Charlotte L Hall, Madeleine J. Groom, Alessio Bellato, Valeria Parlatini
article en

Abstract

Individuals with attention-deficit/hyperactivity disorder (ADHD) exhibit varied responses to pharmacological treatments (e.g. stimulants and non-stimulants). Accurately and promptly detecting treatment-related improvements, response failure, or deterioration poses significant challenges, as current monitoring primarily relies on subjective ratings. In this commentary, we critically evaluate the evidence supporting the use of QbTest for objectively monitoring ADHD treatment response in clinical practice. We also offer recommendations for future research, advocating for rigorous clinical trials and longitudinal studies to further explore the potential utilisation of QbTest and other tools for monitoring treatment responses in individuals with ADHD.

Journal of Child Psychology and PsychiatryVol. 66(2)
University of Nottingham (GB), University of Nottingham Malaysia Campus (MY), King's College London (GB), Solent NHS Trust (GB), NYU Langone Health (US), Institute of Mental Health (GB), Zero to Three (US), NIHR MindTech MedTech Co-operative (GB), Nottingham Biomedical Research Centre (GB), University of Southampton (GB), University of Bari Aldo Moro (IT), New York University (US), Cardiff University (GB)
Wellcome Trust, National Institute for Health and Care Research, Department of Health and Social Care, University of Southampton, Research Executive Agency
Good health and well-being
Openalex Percentile: Top 73%
Attention Deficit Hyperactivity Disorder
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.